ViewRay Announces Conference Call and Webcast of First Quarter 2016 Financial Results to be Held on May 13, 2016

CLEVELAND, May 6, 2016 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2016 financial results, which will take place on Friday, May 13, 2016 before the market opens.

ViewRay will hold a conference call on Friday, May 13, 2016 at 8:30 a.m. ET / 5:30 a.m. PT to discuss the results. The dial-in numbers are 844-277-1426 for domestic callers and 336-525-7129 for international callers. The conference ID number is 7854854. A live webcast of the conference call will be available here or from the investor relations page of ViewRay's corporate website at www.viewray.com.

After the live webcast, a replay of the webcast will remain available online from the investor relations page of ViewRay's corporate website, www.viewray.com, through May 17, 2017. In addition, a telephonic replay of the call will be available until May 20, 2016. The replay dial-in numbers are 855-859-2056 for domestic callers and 404-537-3406 for international callers.  Please use the replay pin number 7854854.

About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.

ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/viewray-announces-conference-call-and-webcast-of-first-quarter-2016-financial-results-to-be-held-on-may-13-2016-300264218.html

SOURCE ViewRay, Inc.

Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.